A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Zoe Moodie, Shuying Sue Li, Elena E. Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp, Shiyu Chen, Kelly E. Seaton, Sheetal S. Sawant, Lu Zhang, Jack Heptinstall, Shuying Liu, Nicole Grunenberg, Frank Tomaka, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Julie A. Ake, Sandhya Vasan, Giuseppe Pantaleo, Ian Frank, Lindsey R. Baden, Paul A. Goepfert, Michael Keefer, Mike Chirenje, Mina C. Hosseinipour, Kathryn Mngadi, Fatima Laher, Nigel Garrett, Linda-Gail Bekker, Stephen De Rosa, Erica Andersen-Nissen, James G. Kublin, Shan Lu, Peter B. Gilbert, Glenda E. Gray, Lawrence Corey, M. Juliana McElrath, Georgia D. Tomaras

Open source

DOI: 10.1080/22221751.2025.2485317
Published: 2025-04-07
Container: Emerging Microbes & Infections
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/22221751.2025.2485317,
  title = {A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials},
  author = {Zoe Moodie and Shuying Sue Li and Elena E. Giorgi and LaTonya D. Williams and One Dintwe and Lindsay N. Carpp and Shiyu Chen and Kelly E. Seaton and Sheetal S. Sawant and Lu Zhang and Jack Heptinstall and Shuying Liu and Nicole Grunenberg and Frank Tomaka and Supachai Rerks-Ngarm and Punnee Pitisuttithum and Sorachai Nitayaphan and Julie A. Ake and Sandhya Vasan and Giuseppe Pantaleo and Ian Frank and Lindsey R. Baden and Paul A. Goepfert and Michael Keefer and Mike Chirenje and Mina C. Hosseinipour and Kathryn Mngadi and Fatima Laher and Nigel Garrett and Linda-Gail Bekker and Stephen De Rosa and Erica Andersen-Nissen and James G. Kublin and Shan Lu and Peter B. Gilbert and Glenda E. Gray and Lawrence Corey and M. Juliana McElrath and Georgia D. Tomaras},
  year = {2025},
  journal = {Emerging Microbes \&amp; Infections},
  doi = {10.1080/22221751.2025.2485317},
  url = {https://doi.org/10.1080/22221751.2025.2485317}
}

RIS

TY  - JOUR
TI  - A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
AU  - Zoe Moodie
AU  - Shuying Sue Li
AU  - Elena E. Giorgi
AU  - LaTonya D. Williams
AU  - One Dintwe
AU  - Lindsay N. Carpp
AU  - Shiyu Chen
AU  - Kelly E. Seaton
AU  - Sheetal S. Sawant
AU  - Lu Zhang
AU  - Jack Heptinstall
AU  - Shuying Liu
AU  - Nicole Grunenberg
AU  - Frank Tomaka
AU  - Supachai Rerks-Ngarm
AU  - Punnee Pitisuttithum
AU  - Sorachai Nitayaphan
AU  - Julie A. Ake
AU  - Sandhya Vasan
AU  - Giuseppe Pantaleo
AU  - Ian Frank
AU  - Lindsey R. Baden
AU  - Paul A. Goepfert
AU  - Michael Keefer
AU  - Mike Chirenje
AU  - Mina C. Hosseinipour
AU  - Kathryn Mngadi
AU  - Fatima Laher
AU  - Nigel Garrett
AU  - Linda-Gail Bekker
AU  - Stephen De Rosa
AU  - Erica Andersen-Nissen
AU  - James G. Kublin
AU  - Shan Lu
AU  - Peter B. Gilbert
AU  - Glenda E. Gray
AU  - Lawrence Corey
AU  - M. Juliana McElrath
AU  - Georgia D. Tomaras
PY  - 2025
JO  - Emerging Microbes &amp; Infections
DO  - 10.1080/22221751.2025.2485317
UR  - https://doi.org/10.1080/22221751.2025.2485317
ER  -

APA

Moodie, Z., Li, S. S., Giorgi, E. E., Williams, L. D., Dintwe, O., Carpp, L. N., Chen, S., Seaton, K. E., Sawant, S. S., Zhang, L., Heptinstall, J., Liu, S., Grunenberg, N., Tomaka, F., Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Ake, J. A., Vasan, S., Pantaleo, G., Frank, I., Baden, L. R., Goepfert, P. A., Keefer, M., Chirenje, M., Hosseinipour, M. C., Mngadi, K., Laher, F., Garrett, N., Bekker, L., Rosa, S. D., Andersen-Nissen, E., Kublin, J. G., Lu, S., Gilbert, P. B., Gray, G. E., Corey, L., McElrath, M. J., & Tomaras, G. D. (2025). A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2025.2485317

Source records

crossref · retrieved 2026-09-27T08:38:02.894Z